CardioNerds Journal Club (@cardionerdsjc) 's Twitter Profile
CardioNerds Journal Club

@cardionerdsjc

A monthly #Cardiology journal club that meets on Twitter produced by @CardioNerds‼️ Use #CardsJC & join the conversation!

ID: 1347358663082725376

linkhttp://www.cardionerds.com calendar_today08-01-2021 01:45:44

1,1K Tweet

8,8K Followers

848 Following

Alison L. Bailey, MD (@a_l_bailey) 's Twitter Profile Photo

🥕Devesh Rai, MD🥕 Worldwide 👩‍🦰are about 25-30% of #STEMIs and 30-40% of #ACS cases so at least that? Great question and we have to continue to work to enroll women in trials. We know women are LESS LIKELY to enroll historically. #CardsJC CardioNerds Journal Club

CardioNerds Journal Club (@cardionerdsjc) 's Twitter Profile Photo

Any thoughts about the implications of the signal suggesting an excess of coronary events in the aspirin-free group? ❤️‍🩹 #CardsJC

Any thoughts about the implications of the signal suggesting an excess of coronary events in the aspirin-free group? ❤️‍🩹
#CardsJC
Ty Gluckman (@tygluckman) 's Twitter Profile Photo

CardioNerds Journal Club This finding provides support for use of aspirin (as part of dual antiplatelet therapy) in the earliest periods post PCI. Given findings from other studies evaluating early transition from dual to antiplatelet monotherapy, aspirin (up to 1 month) is beneficial.

CardioNerds Journal Club (@cardionerdsjc) 's Twitter Profile Photo

How do you think the difference on prasugrel reduced doses 📉 protocol approved only in Japan impacted the results of this study? #CardsJC

How do you think the difference on prasugrel reduced doses 📉 protocol approved only in Japan impacted the results of this study?
#CardsJC
Alison L. Bailey, MD (@a_l_bailey) 's Twitter Profile Photo

A7. Aspirin is still hard to beat! When used in appropriate dosing (low) and in the right clinical context (short-term, post-PCI, post-ACS) #CardsJC @cardionerds @cardionerdsjc

Anezi Uzendu, MD (@druzendu) 's Twitter Profile Photo

Alison L. Bailey, MD CardioNerds CardioNerds Journal Club I agree. The Prasugrel dosing is low and isn't used in the US. In addition, most bleeding was access site bleeding which probably has more to do with the periprocedural antiplatelet and anticoagulant meds than the subacute oral meds. Limiting IIBIIIA, high radial access= ↘️🩸

CardioNerds Journal Club (@cardionerdsjc) 's Twitter Profile Photo

Is the non-inferiority in CV events and lack of superiority in bleeding risk, comparing aspirin-free therapy vs DAPT one month after PCI, believable? #CardsJC

Is the non-inferiority in CV events and lack of superiority in bleeding risk, comparing aspirin-free therapy vs DAPT one month after PCI, believable?
#CardsJC
Alison L. Bailey, MD (@a_l_bailey) 's Twitter Profile Photo

A8. I'm certain. I was not familiar with this dose of prasugrel until reading this trial. 3.75 mg seems << than 10 mg that is the standard dose. I'd be interested in hearing Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP,CACP and Eugene Yang thoughts here. #CardsJC CardioNerds Journal Club

Ty Gluckman (@tygluckman) 's Twitter Profile Photo

CardioNerds Journal Club I don't believe that the findings from this study provide support to omit aspirin immediately post PCI. Fortunately, other studies evaluating this (e.g., LEGACY trial [clinicaltrials.gov/study/NCT05125…]) will help to provide greater insight on this topic.

CardioNerds Journal Club (@cardionerdsjc) 's Twitter Profile Photo

Clinically, this is relevant since no aspirin might not be the answer for fewer bleeding events. Moreover, there could be a signal for higher coronary events (a 3-fold higher rate of stent thrombosis).

Clinically, this is relevant since no aspirin might not be the answer for fewer bleeding events. Moreover, there could be a signal for higher coronary events (a 3-fold higher rate of stent thrombosis).
Alison L. Bailey, MD (@a_l_bailey) 's Twitter Profile Photo

I was impressed with 93% rate of intravascular imaging. Maybe with excellent stent deployment aspirin is all that is needed? And low-dose prasugrel didn't add anything? Curious to see what super ⭐️think Dr. Deepak L. Bhatt Hany Ragy MIЯVΛƬ #IC Dr Roxana Mehran #CardsJC CardioNerds Journal Club

CardioNerds Journal Club (@cardionerdsjc) 's Twitter Profile Photo

Takeaway: STOPDAPT-3 challenges the status quo to tailored antiplatelet therapy post-stenting, especially in the high bleeding risk population. What trial would you like to see in the headlines? #CardsJC

Takeaway: STOPDAPT-3 challenges the status quo to tailored antiplatelet therapy post-stenting, especially in the high bleeding risk population.

What trial would you like to see in the headlines?

#CardsJC
CardioNerds Journal Club (@cardionerdsjc) 's Twitter Profile Photo

Have you adjusted your DAPT strategy post-PCI based on any recent trials? Share your experiences and thoughts! 💬❤️👇 #InterventionalCardiology #CardsJC

Anezi Uzendu, MD (@druzendu) 's Twitter Profile Photo

CardioNerds Journal Club Another practical consideration long term: most of our surgical colleagues are comfortable operating on aspirin. How do they feel operating on SAPT? Will we have to switch SAPT to aspirin then back to SAPT? Look forward to seeing how the science continues to advance. #CardsJC